Venture Development Director, BioCity

Colin is Venture Development Director and a key member of Leadership Team at BioCity Group and an Investor Director for BioCity portfolio company SujiBFR. BioCity is the largest life sciences and health technologies incubator & accelerator in the UK and one of the leading investors in early stage life science companies. As leader of the BioCity Group Venture Development team he is responsible for all venture building activity across the UK and the development of the BioCity investment pipeline.

Previously Colin was a core team member of a successfully exited, VC backed med tech spin out from Edinburgh University (Voxar Ltd), which became a world leader in 3D medical visualisation and image processing algorithms. Following the acquisition he played a key role in the establishment of a new medical software business unit at Barco N.V. a BEL20 blue chip technology company before joining global multinational Toshiba Medical Systems Corporation (now part of Canon Medical Systems), where he led strategic business planning & innovation related to medical imaging software R&D. He led several global strategic initiatives including successful development of the C-level business case for a multi-million dollar AI driven clinical imaging platform. At Toshiba he held the prestigious position of Toshiba Fellow for medical software R&D. Author or co-author on 5 medical imaging and image processing patents.


22 June 2021


HealthTech Integrates Logo

20 June 2023
Leonardo Royal Hotel
London Tower Bridge